YMAB logo
YMAB NASDAQ US

Y-mAbs Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Sep 2018
$8.61
+0.0 (+0.0%)
5
Quality Score
fail
Mkt Cap
$391.2M
ROE
-24.6%
Margin
-26.0%
D/E
0.00
Beta
-0.58
52W
$4–$9

Wall Street Consensus

16 analysts · Jan 2026
0
Strong Buy
0
Buy
13
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

AURA
Aura Biosciences Inc
$346.1M
VNDA
Vanda Pharmaceuticals Inc
$521.2M
AVTX
Avalo Therapeutics Inc
$329.3M
STRO
Sutro Biopharma Inc
$98.6M
RCKT
Rocket Pharmaceuticals Inc
$379.9M
IPSC
Century Therapeutics Inc
$87.0M
ENTA
Enanta Pharmaceuticals Inc
$455.2M

Earnings

Beat rate: 75.0%
Next Report May 11, 2026
EPS Estimate: $-0.26
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.26 — —
Jun 2025 $-0.27 $-0.07 +$0.20
Mar 2025 $-0.22 $-0.12 +$0.10
Dec 2024 $-0.13 $-0.15 $-0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -24.6% -24.6% -24.6% -24.6% -24.6% -24.6%
P/E (TTM) — — — — — —
Net Margin -16.6% -26.0% -26.0% -26.0% -26.0% -26.0%
Gross Margin 86.4% 81.8% 81.8% 81.8% 81.8% 81.8%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 4.00 4.00 4.00 4.00 4.00 4.00

Key Ratios

ROA (TTM)
-18.9%
P/S (TTM)
4.58
P/B
3.8
EPS (TTM)
$-0.49
CF/Share
$-0.42
Rev Growth 3Y
+36.0%
52W High
$8.62
52W Low
$3.55
$3.55 52-Week Range $8.62

How does YMAB compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

YMAB AAPG ABEO ABOS ABP

YMAB valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
4.6
▼ 64% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
3.8
▲ 55% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

YMAB profitability vs Biotechnology peers

ROE
-24.6%
▲ 63% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-26.0%
▲ 91% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
81.8%
▲ 4% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-18.9%
▲ 60% above peers (-46.7%)
vs Peers
vs Industry
Top tier

YMAB financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.0
▼ 10% below peers (4.4)
vs Peers
vs Industry
In line
Beta
-0.6
▼ 160% below peers (1.0)
vs Peers
vs Industry
More volatile

YMAB fundamentals radar

YMAB Peer median Industry

YMAB profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

YMAB vs peers: key metrics

Latest News

No related news yet